Stocks
Grace Therapeutics, Inc.GRCE
NASDAQHealthcareBiotechnology$1.89
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing therapies for rare diseases and unmet medical needs. Its lead product candidate targets a niche patient population, and investors track the stock for its clinical milestones and potential regulatory approvals.
52W Range: $1.79-$5.18
Congressional Interest in Grace Therapeutics, Inc. (GRCE)
No congressional trades have been disclosed for Grace Therapeutics, Inc. (GRCE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading GRCE?
No congressional trades found for this stock.